Under pressure from copycats, Roche sues Pfizer over Herceptin rival
As biosimilar competition puts a squeeze on Roche’s revenue, the company is launching a legal battle against Pfizer and its copycat version of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
